Key Account Management Consulting for Strategic Growth

Our key account management consulting helps B2B and pharma organizations build scalable KAM programs that align strategy, data, and cross-functional teams. We clarify governance, unify commercial and medical functions, modernize account insights with AI-driven analytics, and demonstrate measurable ROI. For more info: https://www.zs.com/capabilitie....s/sales/key-account-

Customer Experience Consulting for Growth & Loyalty

Leading customer experience consulting firms blend human insight with AI and advanced analytics to embed intelligence across every touchpoint. From decoding customer needs through behavioral research, to scaling personalization via automation, to unifying marketing, sales, and service operations — the goal is consistent, omnichannel engagement. For more info: https://www.zs.com/capabilitie....s/customer-experienc

Generative AI for Marketing: 4 Impact Focus Areas

Generative AI isn’t just ready for primetime—it’s already making significant contributions to marketing. Most brands now ask “How?” and “How quickly?” to adopt generative AI for marketing. A pragmatic, phased approach starts with productivity gains, then moves to custom capabilities. For more info: https://www.zs.com/insights/ge....nerative-ai-marketin

Leading Medical Affairs Consulting for Evidence Generation Teams

Medical affairs and evidence generation teams are converging as a strategic powerhouse. Expert medical affairs consulting helps you lead the way by scaling science, insights and customer engagement at every stage in the product life cycle. For more info: https://www.zs.com/capabilitie....s/research-and-devel

First Launch Insights for Emerging Pharma Companies in the US

Drawing on over a decade of U.S. data, this analysis explores how emerging pharma companies approach their first product launches. Key findings show the vast majority commercialize independently, with more than half targeting rare diseases. Advanced modalities now represent a growing share of all first launches. For more info: https://www.zs.com/insights/us....-biotech-and-pharma-